pKLV2-U6gRNA5(Empty)-PGKmCherry2AGFP-W Citations (2)
Originally described in: A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia.Tzelepis K, Koike-Yusa H, De Braekeleer E, Li Y, Metzakopian E, Dovey OM, Mupo A, Grinkevich V, Li M, Mazan M, Gozdecka M, Ohnishi S, Cooper J, Patel M, McKerrell T, Chen B, Domingues AF, Gallipoli P, Teichmann S, Ponstingl H, McDermott U, Saez-Rodriguez J, Huntly BJ, Iorio F, Pina C, Vassiliou GS, Yusa K Cell Rep. 2016 Oct 18;17(4):1193-1205. doi: 10.1016/j.celrep.2016.09.079. PubMed Journal
Articles Citing pKLV2-U6gRNA5(Empty)-PGKmCherry2AGFP-W
| Articles |
|---|
| Comparative Transcriptome Analysis Reveals the Role of the FST Gene in Goose Muscle Development. Wang C, Liu Y, Li M, Yang Y, Dai J, Chen S, Wang H, He D. Animals (Basel). 2025 Oct 16;15(20):3009. doi: 10.3390/ani15203009. PubMed |
| CDK4/6 inhibition overcomes venetoclax resistance mechanisms with enhanced combination activity in acute myeloid leukemia. Stewart ML, Gibbs J, Watanabe-Smith K, Nguyen A, Kenna I, Thiel-Klare K, Kaempf A, Bottomly D, Kurtz SE, Eide CA, Long N, Saultz JN, Sax L, Huang A, McWeeney SK, Chang BH, Tyner JW. Cell Rep Med. 2026 Jan 20;7(1):102526. doi: 10.1016/j.xcrm.2025.102526. Epub 2025 Dec 29. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.